New CDC data on antimicrobial resistance

Read new report: How COVID-19 impacted antimicrobial resistance

Special Report Finds Resistant Infections Surged in Hospitals in 2020

Today, CDC released a new report finding that much of the progress made in the United States in previous years combating antimicrobial resistance (AR) was lost, in large part, due to the effects of the COVID-19 pandemic. The report, COVID-19: U.S. Impact on Antimicrobial Resistance, Special Report 2022, concludes that the threat of antimicrobial-resistant infections is not only still present but has gotten worse—with resistant hospital-onset infections and deaths both increasing at least 15% during the first year of the pandemic. "These setbacks can and must be temporary," CDC Director Rochelle Walensky, MD, MPH said in the report. “The COVID-19 pandemic has made it clear—prevention is preparedness.”

	New @CDC_AR report shows #AntibioticResistance infections and antibiotic use surged in 2020—especially in U.S. hospitals. More prevention actions are needed. Read the report: https://bit.ly/3AlJxiF

Centers for Disease Control and Prevention 1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348 Questions or Problems  |  Unsubscribe